Thomas J Schnitzer

Grants

Grants per year 2002 2024

• 19 Active
• 79 Finished

Grants per year

Search results

• Finished

  Increasing Bone Mass and Bone Strength in Individuals with Chronic Spinal Cord Injury: Maximizing Response to Therapy

  Schnitzer, T. J.

  U.S. Army Medical Research and Materiel Command

  9/30/16 → 3/29/19

  Project: Research project

  • Bone and Bones 100%
  • Spinal Cord Injuries 94%
  • Teriparatide 86%
  • Alendronate 40%
  • Therapeutics 22%

• Prot #A4091056: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Analgesic Efficacy and Safety of a Dose Titration Regimen for the Subcutaneous Administration of Tanezumab in Subjects with Osteoarthritis of the Hip or Knee

  Schnitzer, T. J.

  INC Research, LLC, Pfizer Inc.

  8/2/16 → 8/2/19

  Project: Research project

• Cortico-striatal plasticity in the transition to chronic pain

  Apkarian, A., Griffith, J. W., Martina, M., Parrish, T. B., Procissi, D., Schnitzer, T. J. & Surmeier Jr, D. J.

  National Institute of Dental and Craniofacial Research

  7/1/16 → 12/31/18

  Project: Research project

• Brain mechanisms for clinical placebo in chronic pain

  Apkarian, A., Cella, D., Gershon, R., Parrish, T. B., Schnitzer, T. J. & Griffith, J. W.

  National Center for Complementary and Integrative Health

  6/1/16 → 5/31/18

  Project: Research project

• Prot #AXS02-K301: COAST-1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study- A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Kn

  Schnitzer, T. J.

  Axsome Therapeutics, Inc.

  3/15/16 → 11/30/20

  Project: Research project

• Prot #R475-PN-1524: A Randomized, Double-blind, Multi-dose, Placebo-controlled Phase 2/3 Study to Evaluate the Efficacy and Safety of Fasinumab in Patients with Moderate to Severe Chronic Low Back Pain

  Schnitzer, T. J.

  ICON Clinical Research, LLC, Regeneron Pharmaceuticals, Inc.

  3/10/16 → 4/15/21

  Project: Research project

• Prot #AXS02-301: CREATE-1 Study: CRPS Treatment Evaluation 1 Study: A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional

  Schnitzer, T. J.

  Axsome Therapeutics, Inc.

  3/10/16 → 3/10/19

  Project: Research project

• Functional Performance Evaluation of the Northwestern University Flexible Sub-Ischial Vacuum (NU-FlexSIV) Socket for Persons with Transfemoral Amputation

  Fatone, S. & Schnitzer, T. J.

  U.S. Army Medical Research and Materiel Command

  9/30/15 → 9/29/20

  Project: Research project

  • amputation 100%
  • limbs (animal) 85%
  • prostheses 44%
  • hips 29%
  • quality of life 29%

• Prot #A4091064: A Phase 3, Multicenter, Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement

  Schnitzer, T. J.

  inVentiv Health Clinical, Pfizer Inc.

  9/11/15 → 9/11/19

  Project: Research project

• Prot #A4091059: A Phase 3, Randomized, Double Blind, Placebo and Active Controlled, Multicenter, Parallel Group Study of the Analgesic Efficacy and Safety of Tanezumab in Adult Subjects with Chronic Low Back Pain

  Schnitzer, T. J.

  INC Research, LLC, Pfizer Inc.

  9/11/15 → 9/11/21

  Project: Research project

• Prot #42160443PAI3001: Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Adjunctive Therapy in Subjects with Signs and Symptoms of Osteoarthritis of the Hip or Knee

  Schnitzer, T. J.

  inVentiv Health Clinical, Janssen Research & Development, LLC

  7/22/15 → 7/22/18

  Project: Research project

• Prot #42160443PAI3002: Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects with Signs and Symptoms of Osteoarthritis of the Hip or Knee

  Schnitzer, T. J.

  inVentiv Health Clinical, Janssen Research & Development, LLC

  7/22/15 → 7/22/18

  Project: Research project

• Prot #R475-PN-1227: A Randomized, Double-Blind, Parallel-Group, Dose-Ranging Study of the Efficacy and Safety of REGN475 in Patients with Osteoarthritis of the Knee/Hip who have an Inadequate Response to NSAID and Opioid Therapy

  Schnitzer, T. J.

  Parexel, Regeneron Pharmaceuticals, Inc.

  6/22/15 → 6/22/18

  Project: Research project

• Prot #M14-171: A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of ABT-981 to Placebo in Subjects with Erosive Hand Osteoarthritis

  Schnitzer, T. J.

  AbbVie Inc.

  4/7/15 → 4/7/18

  Project: Research project

• Prot #DS5565-A-E312: An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated with Fibromyalgia

  Schnitzer, T. J.

  INC Research, LLC, Daiichi Sankyo Development Ltd.

  1/8/15 → 9/8/16

  Project: Research project

• Prot #191622-145: BOTOX® Efficacy and Safety in the Treatment of Knee Osteoarthritis

  Schnitzer, T. J.

  Allergan Sales, LLC

  12/12/14 → 1/31/17

  Project: Research project

• Prot #DS5565-A-E311: A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 in Subjects with Pain Associated with Fibromyalgia

  Schnitzer, T. J.

  INC Research, LLC, Daiichi Sankyo Development Ltd.

  12/9/14 → 12/9/17

  Project: Research project

• Prevention of Bone Loss after Acute SCI by Zoledronic Acid: Durability, Effect on Bone Strength and Use of Biomarkers to Guide Therapy

  Schnitzer, T. J. & Griffith, J. W.

  U.S. Army Medical Research and Materiel Command

  9/30/14 → 3/28/21

  Project: Research project

  • Spinal Cord Injuries 100%
  • Zoledronic Acid 94%
  • Bone and Bones 64%
  • Biomarkers 39%
  • Pharmaceutical Preparations 19%

• Prot #M13-741: A Phase 2a Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients with Knee Osteoarthritis

  Schnitzer, T. J.

  AbbVie Inc.

  5/20/14 → 5/20/18

  Project: Research project

• Brain mechanisms for clinical placebo in chronic pain

  Apkarian, A., Cella, D., Gershon, R., Mohr, D. C., Parrish, T. B., Schnitzer, T. J. & Griffith, J. W.

  National Center for Complementary and Integrative Health

  9/30/13 → 5/31/16

  Project: Research project

  • Chronic Pain 100%
  • Placebos 85%
  • Back Pain 71%
  • Brain 42%
  • Clinical Trials 19%

• Brain imaging based strategies for treating UCPPS pain

  Apkarian, A., Parrish, T. B., Schaeffer, A. J. & Schnitzer, T. J.

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/27/13 → 9/26/16

  Project: Research project

  • Pelvic Pain 100%
  • Chronic Pain 80%
  • Neuroimaging 47%
  • Pain 39%
  • Placebos 27%

• A prospective study of human bone adaptation using a novel in-vivo loading model

  Schnitzer, T. J.

  Worcester Polytechnic Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases

  8/16/13 → 8/31/16

  Project: Research project

  • bones 100%
  • prospective studies 80%
  • radius (bone) 36%
  • physical activity 22%
  • muscles 12%

• A Prospective Study of Human Bone Adaptation Using a Novel In-Vivo Loading Model

  Schnitzer, T. J.

  University of Illinois at Chicago, National Institute of Arthritis and Musculoskeletal and Skin Diseases

  9/17/12 → 8/31/16

  Project: Research project

• Cortico-Striatal Plasticity in the Transition to Chronic Pain

  Apkarian, A., Griffith, J. W., Martina, M., Parrish, T. B., Procissi, D., Schnitzer, T. J. & Surmeier Jr, D. J.

  National Institute of Dental and Craniofacial Research

  7/1/12 → 6/30/16

  Project: Research project

• Prot# 20101217: A Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Denosumab Compared With Risedronate in Glucocorticoid-treated Individuals

  Schnitzer, T. J.

  Amgen, Inc.

  5/17/12 → 5/17/18

  Project: Research project